Showing results (61-70 of 102) with videos related to
Sort By:
Pageof 11
Nature Communications|December 5, 2014
Enrichment of CD56(dim)KIR + CD57 + highly cytotoxic NK cells in tumour-infiltrated lymph nodes of melanoma patientsTalib Hassan Ali, Simona Pisanti, Elena Ciaglia, et al.Plos One|April 22, 2009
High levels of exosomes expressing CD63 and caveolin-1 in plasma of melanoma patientsMariantonia Logozzi, Angelo De Milito, Luana Lugini, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 26, 2012
Long-term results of the randomized phase III trial EORTC 18991 of adjuvant therapy with pegylated interferon alfa-2b versus observation in resected stage III melanomaAlexander M M Eggermont, Stefan Suciu, Alessandro Testori, et al.The Journal of Investigative Dermatology|April 9, 2010
Heterogeneous phenotype of human melanoma cells with in vitro and in vivo features of tumor-initiating cellsMichela Perego, Monica Tortoreto, Gabrina Tragni, et al.The Lancet. Oncology|August 17, 2012
Ipilimumab and fotemustine in patients with advanced melanoma (NIBIT-M1): an open-label, single-arm phase 2 trialAnna Maria Di Giacomo, Paolo A Ascierto, Lorenzo Pilla, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 11, 2013
Adjuvant ganglioside GM2-KLH/QS-21 vaccination versus observation after resection of primary tumor > 1.5 mm in patients with stage II melanoma: results of the EORTC 18961 randomized phase III trialAlexander M M Eggermont, Stefan Suciu, Piotr Rutkowski, et al.Journal for Immunotherapy of Cancer|January 4, 2024
Multistep tumor genetic evolution and changes in immunogenicity trigger immune-mediated disease eradication in stage IV melanoma: lessons from a single caseViviana Vallacchi, Elisabetta Vergani, Mara Cossa, et al.Cancer Research|May 3, 2006
Immunization of stage IV melanoma patients with Melan-A/MART-1 and gp100 peptides plus IFN-alpha results in the activation of specific CD8(+) T cells and monocyte/dendritic cell precursorsTiziana Di Pucchio, Lorenzo Pilla, Imerio Capone, et al.Journal of the National Comprehensive Cancer Network : JNCCN|July 26, 2021
Survival in Patients With Sentinel Node-Positive Melanoma With Extranodal ExtensionAndrea Maurichi, Francesco Barretta, Roberto Patuzzo, et al.The Lancet. Oncology|February 3, 2020
Adjuvant dabrafenib plus trametinib versus placebo in patients with resected, BRAFV600-mutant, stage III melanoma (COMBI-AD): exploratory biomarker analyses from a randomised, phase 3 trialReinhard Dummer, Jan C Brase, James Garrett, et al.Pageof 11